The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trajectories of cancer-related behavioral symptoms (CRBS) burden after breast cancer (BC).
 
Martina Pagliuca
Travel, Accommodations, Expenses - Gilead Sciences
 
Julie Havas
No Relationships to Disclose
 
Pietro Lapidari
Travel, Accommodations, Expenses - Lilly
 
Gwenn Menvielle
No Relationships to Disclose
 
Leonor Fasse
Employment - GlaxoSmithKline
Consulting or Advisory Role - Pierre Fabre
Research Funding - Amgen Foundation (Inst); GlaxoSmithKline; GlaxoSmithKline
 
Diane Boinon
Honoraria - MSD
 
Anne-Laure Martin
No Relationships to Disclose
 
Sibille Everhard
No Relationships to Disclose
 
Christelle Jouannaud
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - MSD Oncology; Viatris
 
Marion Fournier
No Relationships to Disclose
 
William Jacot
Honoraria - AstraZeneca; BMSi; Daiichi Sankyo Europe GmbH; Eisai; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; BMSi; Daiichi Sankyo Europe GmbH; Eisai; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca/Daiichi Sankyo (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
 
Laurence Vanlemmens
No Relationships to Disclose
 
Coureche Kaderbhai
No Relationships to Disclose
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; sanofi/3A; Seagen; Viatris
Travel, Accommodations, Expenses - AstraZeneca; BMS; Chugai Pharma; Eisai; Eisai; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology
 
Michelino De Laurentiis
Honoraria - Lilly; Menarini
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Genetic Spa; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Tomalab
 
Florian Scotte
Honoraria - Amgen; BMS GmbH & Co. KG; Daichy Sankyo; Gilead Sciences; GlaxoSmithKline; Leo Phar; Pfizer; Pharmanovia; Thermofisher Scientific Biomarkers; Viatris
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Pfizer
 
Stefan Michiels
Consulting or Advisory Role - Biophytis; IQvia; Kedrion Biopharma; Roche; SERVIER; Yuhan
 
Maria Alice B Franzoi
Speakers' Bureau - Novartis (Inst)
Research Funding - Resilience Care (Inst); Resilience Care (Inst)
 
Ines Maria Vaz Duarte Luis
Honoraria - AstraZeneca (Inst); Novartis (Inst); Sandoz
Research Funding - Resilience Care (Inst)
Travel, Accommodations, Expenses - Novartis; Novartis
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io